Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 10/29/2025 | Q3 | -- | $20.8B | $0.41 | -- | -- |
| 07/30/2025 | Q2 | -- | $18.2B | $0.26 | -- | -- |
| 04/30/2025 | Q1 | -- | $14.3B | $0.26 | -- | -- |
| 02/20/2025 | Q4 | -- | $26.4B | $0.82 | -- | -- |
| 10/30/2024 | Q3 | -- | $17.2B | $0.34 | -- | -- |
| 07/30/2024 | Q2 | -- | $17.2B | $0.08 | -- | -- |
| 04/25/2024 | Q1 | -- | $13.9B | $0.20 | -- | -- |
| 02/15/2024 | Q4 | -- | $24.6B | $0.50 | -- | -- |
| 11/08/2023 | Q3 | -- | $16.2B | $0.28 | -- | -- |
| 07/26/2023 | Q2 | -- | $17.3B | $0.37 | -- | -- |
| 05/03/2023 | Q1 | -- | $12.6B | $0.16 | -- | -- |
| 02/16/2023 | Q4 | -- | $21.1B | $0.54 | -- | -- |
| 10/28/2022 | Q3 | -- | $13.4B | $0.21 | -- | -- |
| 07/27/2022 | Q2 | -- | $13.6B | $0.23 | -- | -- |
| 05/04/2022 | Q1 | -- | $13.5B | $0.43 | -- | -- |
| 02/17/2022 | Q4 | -- | $19.4B | $0.57 | -- | -- |
| 10/28/2021 | Q3 | -- | $12.4B | $0.15 | -- | -- |
| 07/29/2021 | Q2 | -- | $17.1B | $0.72 | -- | -- |
| 04/29/2021 | Q1 | -- | $12.6B | $0.14 | -- | -- |
| 02/18/2021 | Q4 | -- | $23.5B | $0.59 | -- | -- |
| 10/29/2020 | Q3 | -- | $13.1B | -$0.29 | -- | -- |
| 07/30/2020 | Q2 | -- | $9.2B | -$0.51 | -- | -- |
| 04/29/2020 | Q1 | -- | $11.7B | -$0.17 | -- | -- |
| 02/13/2020 | Q4 | -- | $26.9B | -$1.26 | -- | -- |
| 10/30/2019 | Q3 | -- | $17B | $0.35 | -- | -- |
| 07/31/2019 | Q2 | -- | $20.6B | $0.42 | -- | -- |
| 04/30/2019 | Q1 | -- | $14.2B | $0.01 | -- | -- |
| 02/14/2019 | Q4 | -- | $26.6B | $0.59 | -- | -- |
| 10/31/2018 | Q3 | -- | $18B | $0.36 | -- | -- |
| 07/26/2018 | Q2 | -- | $17.7B | $0.08 | -- | -- |
| 04/27/2018 | Q1 | -- | $12.4B | $0.11 | -- | -- |
| 02/15/2018 | Q4 | -- | $24.7B | $0.37 | -- | -- |
| 10/31/2017 | Q3 | -- | $15.1B | $0.12 | -- | -- |
| 07/27/2017 | Q2 | -- | $15.1B | $0.24 | -- | -- |
| 04/27/2017 | Q1 | -- | $12.2B | $0.14 | -- | -- |
| 02/22/2017 | Q4 | -- | $25.7B | -$0.29 | -- | -- |
| 10/26/2016 | Q3 | -- | $15.6B | $0.02 | -- | -- |
| 07/27/2016 | Q2 | -- | $18.6B | $0.49 | -- | -- |
| 03/31/2016 | Q1 | -- | $13.4B | $0.14 | -- | -- |
| 12/31/2015 | Q4 | -- | $23.5B | $0.28 | -- | -- |
Airbus SE reported $20.8B worth of top line sales in its most recent quarter.
Airbus SE announced earnings per share of $0.41 which represents a beat of analyst forecast a -- per share.
Airbus SE reported $3.4B that represents $1.08 per share over the last quarter.
Airbus SE's earnings are forecast to grow from $1.45 per share to -- per share next year representing an increase of --.
Airbus SE's next earnings date is February 19, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.